Sufentanil Citrate is a Epidural; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Sufentanil Citrate.
| Product ID | 0409-3382_18ccc0d5-119e-40a1-8929-3e7045e41457 |
| NDC | 0409-3382 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sufentanil Citrate |
| Generic Name | Sufentanil Citrate |
| Dosage Form | Injection, Solution |
| Route of Administration | EPIDURAL; INTRAVENOUS |
| Marketing Start Date | 2005-07-26 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA074534 |
| Labeler Name | Hospira, Inc. |
| Substance Name | SUFENTANIL CITRATE |
| Active Ingredient Strength | 50 ug/mL |
| Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
| DEA Schedule | CII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2005-07-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA074534 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2005-10-25 |
| Marketing Category | ANDA |
| Application Number | ANDA074534 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-08-16 |
| Marketing Category | ANDA |
| Application Number | ANDA074534 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2005-07-26 |
| Marketing End Date | 2015-02-23 |
| Marketing Category | ANDA |
| Application Number | ANDA074534 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2005-07-26 |
| Marketing Category | ANDA |
| Application Number | ANDA074534 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-08-16 |
| Marketing Category | ANDA |
| Application Number | ANDA074534 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2005-10-25 |
| Marketing End Date | 2015-02-23 |
| Marketing Category | ANDA |
| Application Number | ANDA074534 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2005-08-08 |
| Marketing End Date | 2015-02-23 |
| Marketing Category | ANDA |
| Application Number | ANDA074534 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2005-08-08 |
| Marketing Category | ANDA |
| Application Number | ANDA074534 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-08-16 |
| Ingredient | Strength |
|---|---|
| SUFENTANIL CITRATE | 50 ug/mL |
| SPL SET ID: | 20293943-46ff-4345-1aa4-929b4e017a25 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0409-3382 | Sufentanil Citrate | SUFENTANIL CITRATE |
| 0641-6110 | Sufentanil Citrate | Sufentanil Citrate |
| 0641-6111 | Sufentanil Citrate | Sufentanil Citrate |
| 0641-6112 | Sufentanil Citrate | Sufentanil Citrate |
| 17478-050 | Sufentanil Citrate | Sufentanil Citrate |